// App-Quantinova.ai

544 : Improving Prognostication amongst Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma: An International, 16-Center Study to Validate and Recalibrate HALTHCC

Researchers

Presenter

  • D. Firl

Principal Investigators

  • S. Kimura

  • W. Dumronggittigule

  • A. Gorgen

  • J. Lerut

  • M. Rossi

  • U. Cillo

  • A. Viveiros

  • E. Tsochatzis

  • G. Otto

  • G. Ettorre

  • G. Tisone

  • M. Vivarelli

  • S. Agnes

  • J. Markmann

  • T. Ikegami

  • T. Kaido

  • G. Sapisochin

  • V. Agopian

  • Q. Lai

  • F. Aucejo

Medical Centers

  • CCF, Cleveland, OH

  • MGH, Boston

  • UCLA, CA

  • CNN, Toronto, Canada

  • SLH, Louvain, Belgium

  • UH, Rome, Italy

  • UniPD, Padua, Italy

  • MUI, Innsbruck, Austria

  • NCRI, London, United Kingdom

  • Mainz, Germany

  • UH, Rome, Italy

  • UH, Rome, Italy

  • AOU, Torrette Ancona, Italy

  • UH, Rome, Italy

  • KU, Kyoto, Japan

  • KU, Kyushu, Japan

Locations

  • United States

  • Canada

  • Belgium

  • Italy

  • Austria

  • United Kingdom

  • Germany

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved